However, current guidelines suggest that all COPD patients should be checked for α1-AT levels, regardless of age, smoking status, and COPD severity, since current information shows that AATD can also occur in those who do not have the classical phenotype. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.